Primary care providers' experiences with urine toxicology tests to manage prescription opioid misuse and substance use among chronic noncancer pain patients in safety net health care settings

Substance Abuse

Volumn 37, Issue 1, 2016, Pages 154-160

  Ceasar, Rachel ^a,b   Chang, Jamie ^a   Zamora, Kara ^a   Hurstak, Emily ^a   Kushel, Margot ^a   Miaskowski, Christine ^a   Knight, Kelly ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Chronic pain; opioids; urine toxicology screen

Indexed keywords

NARCOTIC ANALGESIC AGENT;

CHRONIC PAIN; COMPLICATION; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; MALE; OPIOID-RELATED DISORDERS; PRIMARY HEALTH CARE; PROCEDURES; SAFETY NET HOSPITAL; SUBSTANCE ABUSE; TOXICITY TESTING; URINE; UTILIZATION;

ANALGESICS, OPIOID; ATTITUDE OF HEALTH PERSONNEL; CHRONIC PAIN; FEMALE; HUMANS; MALE; OPIOID-RELATED DISORDERS; PRIMARY HEALTH CARE; SAFETY-NET PROVIDERS; SUBSTANCE ABUSE DETECTION; TOXICITY TESTS;

EID: 84961644777     PISSN: 08897077     EISSN: 15470164     Source Type: Journal    
DOI: 10.1080/08897077.2015.1132293     Document Type: Article

References (53)

1. Substance Abuse and Mental Health Services Administration. Results From the 2013 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014.
2. Vijayaraghavan M, Penko J, Guzman D, Miaskowski C, Kushel MB. Primary care providers' judgments of opioid analgesic misuse in a community-based cohort of HIV-infected indigent adults. J Gen Intern Med. 2011; 26: 412-418.
3. Khosla N, Juon HS, Kirk GD, Astemborski J, Mehta SH. Correlates of non-medical prescription drug use among a cohort of injection drug users in Baltimore City. Addict Behav. 2011; 36: 1282-1287.
4. Sullivan MD, Von Korff M, Banta-Green C, Merrill JO, Saunders K. Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer pain. Pain. 2010; 149: 345-353.
5. Portenoy RK. Opioid therapy for chronic nonmalignant pain: A review of the critical issues. J Pain Symptom Manage. 1996; 11: 203-217.
6. Jamison RN, Serraillier J, Michna E. Assessment and treatment of abuse risk in opioid prescribing for chronic pain. Pain Res Treat. 2011; 2011: 941808.
7. Robinson RC, Gatchel RJ, Polatin P, Deschner M, Noe C, Gajraj N. Screening for problematic prescription opioid use. Clin J Pain. 2001; 17: 220-228.
8. Levi-Minzi MA, Surratt HL, Kurtz SP, Buttram ME. Under treatment of pain: A prescription for opioid misuse among the elderly? Pain Med. 2013; 14: 1719-1729.
9. Inciardi JA, Surratt HL, Kurtz SP, Cicero TJ. Mechanisms of prescription drug diversion among drug-involved club-and street-based populations. Pain Med. 2007; 8: 171-183.
10. Katz NP, Adams EH, Benneyan JC, et al. Foundations of opioid risk management. Clin J Pain. 2007; 23: 103-118.
11. Atluri S, Sudarshan G, Manchikanti L. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011. Pain Physician. 2014; 17: E119-E128.
12. Cai R, Crane E, Poneleit K, Paulozzi L. Emergency department visits involving nonmedical use of selected prescription drugs in the United States, 2004-2008. J Pain Palliat Care Pharmacother. 2010; 24: 293-297.
13. Caudill-Slosberg MA, Schwartz LM, Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain. 2004; 109: 514-519.
14. Olsen Y, Daumit GL, Ford DE. Opioid prescriptions by U.S. primary care physicians from 1992 to 2001. J Pain. 2006; 7: 225-235.
15. Gilson AM, Kreis PG. The burden of the nonmedical use of prescription opioid analgesics. Pain Med. 2009; 10 (Suppl 2): S89-S100.
16. Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009; 10: 113-130.
17. Trescot AM, Boswell MV, Atluri SL, et al. Opioid guidelines in the management of chronic non-cancer pain. Pain Physician. 2006; 9: 1-39.
18. Schonwald G. What is the role of urine drug testing (UDT) in the management of chronic non-cancer pain with opioids? Pain Med. 2012; 13: 853-856.
19. Christo PJ, Manchikanti L, Ruan X, et al. Urine drug testing in chronic pain. Pain Physician. 2011; 14: 123-143.
20. Starrels JL, Becker WC, Alford DP, Kapoor A, Williams AR, Turner BJ. Systematic review: Treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Ann Intern Med. 2010; 152: 712-720.
21. O'Rorke JE, Chen I, Genao I, Panda M, Cykert S. Physicians' comfort in caring for patients with chronic nonmalignant pain. Am J Med Sci. 2007; 333: 93-100.
22. Peppin JF, Passik SD, Couto JE, et al. Recommendations for urine drug monitoring as a component of opioid therapy in the treatment of chronic pain. Pain Med. 2012; 13: 886-896.
23. Lewin M, Altman S., eds. America's Health Care Safety Net: Intact But Endangered. Washington, DC: The National Academies Press; 2000.
24. Medical Board of California. Guidelines for Prescribing Controlled Substances for Pain. CA: Medical Board of California; 2014.
25. Office of National Drug Control Policy. National Drug Control Strategy. Washington, DC: Office of National Drug Control Policy, The White House; 2011.
26. Centers for Disease Control and Prevention (CDC). Vital signs: overdoses of prescription opioid pain relievers-United States, 1999-2008. MMWR Morb Mortal Wkly Rep. Nov 4 2011;60(43):1487-1492.
27. Institute of Medicine. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington DC: Institute of Medicine; 2011.
28. Corbin J, Strauss A. Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory. Thousand Oaks, CA: Sage Publications; 2014.
29. Charmaz K. Constructing Grounded Theory. Thousand Oaks, CA: Sage Publications; 2014.
30. Turk DC, Swanson KS, Gatchel RJ. Predicting opioid misuse by chronic pain patients: A systematic review and literature synthesis. Clin J Pain. 2008; 24: 497-508.
31. Moskowitz D, Thom D, Guzman D, Penko J, Miaskowski C, Kushel M. Is primary care providers' trust in socially marginalized patients affected by race? J Gen Intern Med. 2011; 26: 846-851.
32. Hausmann LRM, Gao S, Lee ES, Kwoh CK. Racial disparities in the monitoring of patients on chronic opioid therapy. Pain. 2013; 154: 46-52.
33. Becker WC, Starrels JL, Heo M, Li X, Weiner MG, Turner BJ. Racial differences in primary care opioid risk reduction strategies. Ann Fam Med. 2011; 9: 219-225.
34. Reisfield GM, Graham NA, Gold MS. Urine drug testing is still an invaluable resource for primary care. Ann Intern Med. 2010; 153: 420; author reply 420-421.
35. Starrels JL, Fox AD, Kunins HV, Cunningham CO. They don't know what they don't know: internal medicine residents' knowledge and confidence in urine drug test interpretation for patients with chronic pain. J Gen Intern Med. 2012; 27: 1521-1527.
36. Reisfield GM, Bertholf R, Barkin RL, Webb F, Wilson G. Urine drug test interpretation: what do physicians know? J Opioid Manag. 2007; 3: 80-86.
37. Pesce A, West C, Egan City K, Strickland J. Interpretation of urine drug testing in pain patients. Pain Med. 2012; 13: 868-885.
38. Lange A, Lasser KE, Xuan Z, et al. Variability in opioid prescription monitoring and evidence of aberrant medication taking behaviors in urban safety-net clinics. Pain. 2015; 156: 335-340.
39. Nuckols TK, Anderson L, Popescu I, et al. Opioid prescribing: A systematic review and critical appraisal of guidelines for chronic pain. Ann Intern Med. 2014; 160: 38-47.
40. Cheatle MD, Barker C. Improving opioid prescription practices and reducing patient risk in the primary care setting. J Pain Res. 2014; 7: 301-311.
41. Khalid L, Liebschutz JM, Xuan Z, et al. Adherence to prescription opioid monitoring guidelines among residents and attending physicians in the primary care setting. Pain Med. 2015; 16: 480-487.
42. Broyles LM, Binswanger IA, Jenkins JA, et al. Confronting inadvertent stigma and pejorative language in addiction scholarship: A recognition and response. Subst Abus. 2014; 35: 217-221.
43. Coffin P, Banta-Green C. The dueling obligations of opioid stewardship. Ann Intern Med. 2014; 160: 207-208.
44. Dowell D, Kunins HV, Farley TA. Opioid analgesics-risky drugs, not risky patients. JAMA. 2013; 309: 2219-2220.
45. Rogers WA. Is there a moral duty for doctors to trust patients? J Med Ethics. 2002; 28: 77-80.
46. Dubbin LA, Chang JS, Shim JK. Cultural health capital and the interactional dynamics of patient-centered care. Soc Sci Med. 2013; 93: 113-120.
47. Chang JS, Dubbin L, Shim JK. Negotiating substance use stigma: The role of cultural health capital in provider-patient interactions. Sociol Health Illness. 2015; 38.
48. Gunderson EW, Coffin PO, Chang N, Polydorou S, Levin FR. The interface between substance abuse and chronic pain management in primary care: A curriculum for medical residents. Subst Abus. 2009; 30: 253-260.
49. Canada RE, DiRocco D, Day S. A better approach to opioid prescribing in primary care. J Fam Pract. 2014; 63: E1-E8.
50. Turner JA, Saunders K, Shortreed SM, et al. Chronic opioid therapy risk reduction initiative: impact on urine drug testing rates and results. J Gen Intern Med. 2014; 29: 305-311.
51. Liebschutz JM, Alford DP. Safe opioid prescribing: A long way to go. J Gen Intern Med. 2011; 26: 951-952.
52. Reuben DB, Alvanzo AAH, Ashikaga T, et al. National Institutes of Health Pathways to Prevention Workshop: The role of opioids in the treatment of chronic painthe role of opioids in the treatment of chronic pain. Ann Intern Med. 2015; 162: 295-300.
53. Cristobal K. Striking a Balance: Safety-Net Leaders Explore Solutions to the Prescription Painkiller Epidemic. 2015.